Vaginal progesterone for the prevention of neonatal Respiratory Distress Syndrome - a randomised controlled trial [ 2006 - 2008 ]

Research Grant

Researchers: Prof Caroline Crowther (Principal investigator) ,  Dr Andrew Mcphee ,  Prof Jodie Dodd ,  Prof Vicki Flenady

Brief description Respiratory Distress Syndrome is a significant problem for babies born very preterm (at less than 34 weeks of pregnancy). For these babies, over 90% will require support for their breathing. These babies are also at increased risk of dying, and in survivors, there is a risk of long-term disability. It is uncertain if giving vaginal progesterone therapy during pregnancy to women who have had a previous preterm birth can reduce these risks. This randomised controlled trial will assess the use of vaginal progesterone therapy for women at risk of preterm birth as a means of reducing the risk of neonatal Respiratory Distress Syndrome and improving the outcomes of their babies.

Funding Amount $AUD 1,243,110.94

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant